Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice
Top Cited Papers
Open Access
- 27 June 2011
- Vol. 61 (1) , 69-77
- https://doi.org/10.1136/gut.2011.238386
Abstract
Objectives To estimate, overall and by organism, the incidence of infectious intestinal disease (IID) in the community, presenting to general practice (GP) and reported to national surveillance. Design Prospective, community cohort study and prospective study of GP presentation conducted between April 2008 and August 2009. Setting Eighty-eight GPs across the UK recruited from the Medical Research Council General Practice Research Framework and the Primary Care Research Networks. Participants 6836 participants registered with the 88 participating practices in the community study; 991 patients with UK-acquired IID presenting to one of 37 practices taking part in the GP presentation study. Main outcome measures IID rates in the community, presenting to GP and reported to national surveillance, overall and by organism; annual IID cases and GP consultations by organism. Results The overall rate of IID in the community was 274 cases per 1000 person-years (95% CI 254 to 296); the rate of GP consultations was 17.7 per 1000 person-years (95% CI 14.4 to 21.8). There were 147 community cases and 10 GP consultations for every case reported to national surveillance. Norovirus was the most common organism, with incidence rates of 47 community cases per 1000 person-years and 2.1 GP consultations per 1000 person-years. Campylobacter was the most common bacterial pathogen, with a rate of 9.3 cases per 1000 person-years in the community, and 1.3 GP consultations per 1000 person-years. We estimate that there are up to 17 million sporadic, community cases of IID and 1 million GP consultations annually in the UK. Of these, norovirus accounts for 3 million cases and 130 000 GP consultations, and Campylobacter is responsible for 500 000 cases and 80 000 GP consultations. Conclusions IID poses a substantial community and healthcare burden in the UK. Control efforts must focus particularly on reducing the burden due to Campylobacter and enteric viruses.Keywords
This publication has 28 references indexed in Scilit:
- Epidemiology and Genotype Analysis of Emerging Sapovirus-Associated Infections across EuropeJournal of Clinical Microbiology, 2010
- Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study)BMC Medical Research Methodology, 2010
- Community Incidence of Norovirus-associated Infectious Intestinal Disease in England: Improved Estimates Using Viral Load for Norovirus DiagnosisAmerican Journal of Epidemiology, 2010
- Chicken Consumption and Use of Acid-Suppressing Medications as Risk Factors forCampylobacterEnteritis, EnglandEmerging Infectious Diseases, 2009
- Diagnosing norovirus-associated infectious intestinal disease using viral loadBMC Infectious Diseases, 2009
- Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany in 2004European Journal of Clinical Microbiology & Infectious Diseases, 2009
- Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993–1996)European Journal of Clinical Microbiology & Infectious Diseases, 2007
- Incidence of Guillain‐Barré Syndrome among Patients withCampylobacterInfection: A General Practice Research Database StudyThe Journal of Infectious Diseases, 2006
- Etiology of Gastroenteritis in Sentinel General Practices in The NetherlandsClinical Infectious Diseases, 2001
- The Read clinical classification.BMJ, 1990